Sepracor develops chemical processes for its ICEs by applying its expertise in chiral chemistry against these issues. Sepracor formed a chemistry group to utilize and expand these technologies. This chemistry expertise was expanded over the years by senior scientists from major pharmaceutical companies, who are now focused on developing ICE compounds. As seen from the publication list, the process research and development group utilizes a wide range of innovative approaches on some very challenging synthetic opportunities. In-house method development and validation capabilities are essential for success.
Chiral chromatography is a specialty.
Most recently, Sepracor has established an in-house preformulation capability to develop a wide range of formulation types. Specialty collaborators and a strong preformulation capability make the development process much more efficient. Particle size characterization is critical in many of Sepracor's products. Sepracor Canada Sepracor Canada Ltd is a 25,000 square foot facility located in the Annapolis Valley, Nova Scotia, Canada. Its mandate is to produce quality products for Sepracor within a critical timeline for scaling-up purposes, clinical supplies and commercial use.